Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

TH-9402 covered under U.S. patent

June 21, 1996

Encouraging preclinical results for G-3139

June 21, 1996

Onyx and Lilly expand BRCA1 research agreement

June 21, 1996

Universidad de Salamanca reveals LL-15

June 21, 1996

Breast/prostate cancer treatment agents reported

June 21, 1996

Development of DS-4152 for Kaposi's sarcoma in AIDS patients terminated

June 21, 1996

Potential cancer/nephritis derivatives reported

June 21, 1996

Positive preclinical results for Onconase reported

June 21, 1996

LHRH antagonists disclosed by Takeda

June 21, 1996

Antitumor baccatin derivatives from Tanabe Seiyaku

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 24, 2025.
Regulatory actions for April 24, 2025
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cel-Sci, Novavax,...
Go ask Alis? New fund aims to rescue biopharma’s trapped cash
BioWorld
“They are not zombies, they are fallen angels.” That is view of Nick Johnston, a U.K-based banker who has come up with a new plan to rescue listed companies whose...
Synthetic Design emerges with $20M and next-gen ADC platform
BioWorld
Synthetic Design Lab Inc., which emerged from stealth with a $20 million seed round and a platform technology aimed at advancing the antibody-drug conjugate (ADC)...